Begin main content

News and Events

Latest News

New at CADTH — September 2018

September 17, 2018
Read this month’s issue of New at CADTH. Here, you’ll find the latest information on our products and services, corporate news, and news flashes of upcoming events across Canada.

Call for Patient Input: doravirine

September 14, 2018
CADTH has received the following drug submission(s) and/or notice(s) of pending submission(s). If you are interested in providing patient input, please click on “Submit.” For information about the patient input process or for additional instructions, please see the Patient Input page of our website. doravirine Brand name Generic name Manufacture...

Call for Patient Input: doravirine/lamuvidine/tenofovir disoproxil fumarate

September 14, 2018
CADTH has received the following drug submission(s) and/or notice(s) of pending submission(s). If you are interested in providing patient input, please click on “Submit.” For information about the patient input process or for additional instructions, please see the Patient Input page of our website. doravirine/lamuvidine/tenofovir disoproxil fum...

Upcoming Events

The Aligned Review Process

September 26, 2018
Health Canada, CADTH, and Quebec’s l’Institut national d’excellence en santé et en services sociaux (INESSS) have scheduled a webinar to detail their new aligned review process and to answer any questions stakeholders may have about the initiative. As announced in June 2018, Health Canada, CADTH, and INESSS are increasing their efforts to align ...

2019 CADTH Symposium

April 14, 2019 - April 16, 2019
CADTH will be hosting its annual Symposium at the Shaw Centre in Edmonton, Alberta, from April 14 to 16, 2019. For more information, please visit the CADTH Symposium website. Questions may be sent by email to symposium@cadth.ca.